Evaluation of commercial SARS-CoV-2 serological assays in Canadian public health laboratories

The COVID-19 pandemic has led to the influx of immunoassays for the detection of antibodies towards severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into the global market. The Canadian Public Health Laboratory Network Serology Task Force undertook a nationwide evaluation of twelve labor...

Descripción completa

Detalles Bibliográficos
Autores principales: Stein, Derek R., Osiowy, Carla, Gretchen, Ainsley, Thorlacius, Laurel, Fudge, Denise, Lang, Amanda, Sekirov, Inna, Morshed, Muhammad, Levett, Paul N., Tran, Vanessa, Kus, Julianne V., Gubbay, Jonathan, Mohan, Vandana, Charlton, Carmen, Kanji, Jamil N., Tipples, Graham, Serhir, Bouchra, Therrien, Christian, Roger, Michel, Jiao, Lei, Zahariadis, George, Needle, Robert, Gilbert, Laura, Desnoyers, Guillaume, Garceau, Richard, Bouhtiauy, Ihssan, Longtin, Jean, El-Gabalawy, Nadia, Dibernardo, Antonia, Lindsay, L. Robbin, Drebot, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Inc. 2021
Materias:
Virology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377389/
https://www.ncbi.nlm.nih.gov/pubmed/34425450
http://dx.doi.org/10.1016/j.diagmicrobio.2021.115412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377389/
https://www.ncbi.nlm.nih.gov/pubmed/34425450
http://dx.doi.org/10.1016/j.diagmicrobio.2021.115412

Ejemplares similares